Compounded MK-677 (Ibutamoren)
Check whether compounded MK-677 (Ibutamoren) can be routed, what restrictions may apply, and what to ask your prescriber or pharmacist.
About MK-677 (Ibutamoren)
Important: MK-677 (Ibutamoren) is not currently eligible for compounding by licensed U.S. pharmacies due to FDA restrictions. Quote requests for MK-677 cannot be fulfilled through Compounding Finder.
Key Questions Before You Request Quotes
Can I get MK-677 (Ibutamoren) compounded?
Not through Compounding Finder right now. A prescriber and pharmacist still have to decide whether any compounded MK-677 (Ibutamoren) preparation is legally and clinically appropriate.
Is a prescription needed?
Yes. Patient-specific 503A compounding is based on a valid prescription order or prescriber notation for an identified patient.
What affects price?
Strength, dosage form, quantity, ingredient sourcing, sterile versus non-sterile preparation, shipping requirements, and each pharmacy's workflow can all change the final quote.
How fast can I get quotes?
For routable requests, Compounding Finder typically returns quote options by email within 1-2 business days after you submit the request details.
What happens after I submit?
We review the request, route it to eligible licensed pharmacies, collect available options, and email you the quoted choices. You decide whether to move forward with a pharmacy.
Source notes: FDA explains that compounded drugs are not FDA-approved finished products and describes 503A compounding around patient-specific prescriptions. See Compounding and the FDA and Section 503A.
We Do Not Currently Route MK-677 (Ibutamoren) Quote Requests
MK-677 (Ibutamoren) is not FDA-approved and is not on the FDA 503A bulk substances list, so US compounding pharmacies cannot legally dispense it for human consumption. If FDA guidance changes, we will revisit.